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Objectives. The aim of this study was to assess the occurrence
of the two most commonly encountered aflauchondrial DNA
(mIDNA) deletions in the hearts of patients with idiopathic dilated
cardlomyepathy .
Background. The mutation frequency of natDNA is high, and
sporadic cases. of cardiomyopathles associated with mIDNA dele-
lions ho* ,.. hen itscribed. Reports of increases in mIDNA dele-
tions with advancing age also exist .
mi%wh. %e studied 15 consecutive patients with typical signs
of idiopathic dilated cardiomyopathy, without a family history,
together with 10i control hearts obtained at autopsy from patients
who died of noucardiac causes. The patients underwent both right
and left heart catheterization, dun ing which endomyoc2rdial
biopsy samples were taken. The mtDNA in these samples and in
the control hearts was analyzed by the polymerase chain reaction
technique for the occurrence and proportion of 5- and 7 .40lobase
(kb) deletions (Cambridge sequence map positions from nucle-
otides 849P to 134"47 and 8637 to 16084, respectively) .
Results . The 5-kb mfDNA deletion was observed in the hearts
Idiopathic dilated cardiomyopathy is probably mullifactorial
in origin (1,2), and the possibility of a viral etiology is
supported by increased titers of antibodies to Coxsackie
virus or the occurrence of enterovirus RNA in the cardiac
tissue of some patients (3-5), although the enterovirus hy-
pothesis has been challenged recently (6) . The other major
hypothesis, involving autoimmunity-mediated damage to
myocytes, is supported by the presence of autoantibodies to
apparently normal or abnormal cardiac tissue (7-11) . Defects
in natural killer (12) and suppressor lymphocyte activity
(13,14) and myocyte-specific cytotoxic T-cell responses (15)
have also been detected, arguing for an immunologic etiol-
ogy. Predisposition to the disease may be determined by the
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of all of the patients with idiopathic dilated cardiomyopathy,
accounting for 0.32 :k 0.05% (mean ± SEM) of the total miDNA.
The 7,4-kb deletion was found in 7 of the 15 patients with
idiopathic dilated cardiomyepathy and comprised 0 .28 :t 0.08%
of the total. The 5- and 7.4-kb deletions were detected in 12 and 9
control hearts, respectively, quantitatively similar to the patients
with idiopathic dilated cardiomyopathy . A sigmoidal age depen-
dency of the mIDNA deletions was found both in the patients with
cardiomyopathy and in the control hearts, but after elimination of
the confounding age variable, there was no difference between
these groups .
Conclusions . Because of the similarity of the age-dependent
increase in the frequency of antDNA deletions in cardiomyopethic
and control hearts, the deletions have no causal relation with
idiopathic dilated cardiomyopathy. The present results confirm
the notion of an increase in anIDNA deletions with advancing age
and show that endomyocardial tissue sampling is a feasible
method for detecting mtDNA defects in affected hearts .
U A in Coll Cardiol 1994,23:935-42)
major histocompatibility complex genes (16,17), and Mar-
gossian et al . (18) have recently reported a reduction in the
myocardial regulatory light chain content of myosin (LC2),
related to the presence of an active protease . The protease-
mediated cleavage of LC2 in myosin would, according to
their hypothesis, lead to changes in myosin structure and
function, with signs of idiopathic dilated cardiomyopathy .
Cases of familial aggregation emphasize the potential role
of genetic factors in the pathogenesis of idiopathic dilated
cardiomyopathy (19-22), and some cases of isolated cardio-
myopathy with deletions or point mutations in mitochondrial
DNA (mtDNA) have been described recently (23-27) .
Mitochondrial DNA is a small (16.5-kilobase [kb]), circu-
lar, double-stranded molecule that contains 13 genes for
peptides of the mitochondrial respiratory chain, 2 for mito-
chondrial ribosomal RNAs and genes for all 22 transfer
RNAs required for mitochondrial protein synthesis (Fig . 1)
(28) . Previous research has indicated impaired mitochondrial
function in the failing human heart (29,30), but this has not
been attributed to defects in mtDNA .
Most idiopathic dilated cardiomyopathy seems to he
nonfamilial . However, and as with most mtDNA deletions,
there is no obvious maternal inheritance . We therefore set
0735-1097/94/$7 .00
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Figure 1 . Gene map of the mitochondrial DNA showing the location
and extent of the 5- and 7 .4-kilobase (kb) deletions. PCRI, PCR2 =
regions amplified by the polymerise chain reaction for the detection
of the 5- and 7.4-kb deletions, respectively ; ND 1-5
= nicotinamide
adenine dimucleotide subunit genes (complex 1) ; Cyto B = cyto-
chrome b ; CO = cytochrome oxidase (complex IV); ATPase =
adenosine triphosphate synthetase (complex V) ; f-Met = fMet
peptide; D-loop = displacement loop. Amino acids indicate the
corresponding amino acid transfer RNA genes .
out to study the occurrence of the two most common
mitochondrial defe7ts, the 5- and 7 .4-kb mtDNA deletions
(31,32), in the myocardium of a prospective series of 15
patients with idiopathic dilated cardiomyopathy without any
family history of the disease . Tissue samples were obtained
by endomyocardial biopsy, a technique that we recently
used succesdk$r to diagnose myocardial mtDNA deletion in
a patient with a third-degree atrioventricular block and
Kcams-Sayre syndrome (33) .
Because it has been reported that the frequency of
mtDNA deletions increases with advancing age (32,34-38),
an additional i6 hearts obtained at autopsy from subjects
who died of noncardiac causes were also studied .
Methods
Patients ad dbpodk procedures . These series com-
prised 15 patients with symptoms of heart failure and typical
echocardiographic features of idiopathic dilated cardiomy-
opathy, none of whom had a positive family history of
cardiomyopathy . All of them underwent cardiac catheteriza-
tion. Intracardiac pressures were monitored during right-
sided catheterization, and cardiac output was determined by
the Fick principle. In addition, 10 endomyocardial biopsy
samples were obtained from the right ventricular septum or
apex in each patient, of which 5 were used to analyze tissue
morphology, and 5 were frozen in liquid nitrogen for subse-
quent DNA analysis . Left ventricular pressures were mea-
sured during left-sided catheterization, and ventriculography
and coronary angiography were performed .
All patients n=t be diagno-stic critteena put. fonvard
'
for
idiopathic dilated cardiomyopathy by Manolio et al . (2), and
their clinical characteristics, medication and echocardio-
graphic and catheterization findings are shown in Table 1 .
Most patients were in New York Heart Association func-
tional class 11 to 111
. Mean (±SEM) left ventricular end-
diastolic diameter was 73 ± 2 mm, and mean ejection
fraction was 30 ± 3% by M-mode echocardiography. Only
one patient had signs of coronary artery disease (<50%
diameter stenosis in the left anterior descending coronary
artery), and none had histopathologic signs of active myo-
carditis .
Control samples were obtained at autopsy from the hearts
of 16 subjects who had died of noncardiac causes (Table 2) .
There were no macroscopic or microscopic signs of cardiac
pathology in the control hearts .
The research was approved by the local ethical commit-
tee of the Medical Faculty of Oulu University, and all
patients with idiopathic dilated cardiomyopathy gave in-
formed consent before the catheterization examination .
DNA analysis. Total DNA was isolated from 10 to 30 mg
of endomyocardial biopsy or autopsy sample by sodium
dodecyl sulfate-proteinase K digestion at 42°C, followed by
phenol/chloroformfisoamyl alcohol extraction (39), and the
mtDNA deletions were examined by digesting 2 /Ag of the
total DNA with Pvu II restriction enzyme, which has only
one site for cutting mtDNA and thus linearizes the mtDNA
molecule . The DNA fragments were separated electro-
phoretically and transferred to nitrocellulose filters that were
hybridized with phosphorus-32-radiolabeled whole human
mtDNA and autoradiographed overnight at 72°C using
Kodak XAR film with an intensifying screen .
To detect small amounts of the 5-kb deletion (Cambridge
sequence map position from nucleotide 8469 to 13447) (Fig .
1), the specific proportion of mtDNA was amplified by the
polymerase chain reaction technique (40) . The primers used
for polymerase chain reaction amplification were positioned
at nucleotides 8282 to 8305 and 13851 to 13832 (593 base-pair
product) . The polymerise chain reaction was carried out in
a 100-pJ reaction volume containing 200 JLmolffiter of each
deoxynucleotide triphosphate (deoxyadenosine triphosphate
deoxycytosine triphosphate, deoxyguanosine triphosphate
and deoxythymidine triphosphate), 50 mmollliter of potas-
sium chloride, 1 .5 mmol/liter magnesium chloride, 0.01%
(wt/vol) gelatin, 100 pmol of each primer and 2 .5 IU of Taq
polymerase (Promega) . Twenty-five nanograms of the total
DNA was used for each amplification . There were 30 poly-
merase chain reaction cycles of denaturing at 94°C for 30 s,
annealing at 56°C for 1 min and extension at 72°C for 1 min,
except that the first cycle had 2 min of denaturation . The
generated mtDNA fragments were visualized on 1% agarose
gel with ethidium bromide .
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Table 1 . Clinical Characteristics of Patients With Dilated Cardiomyopathy
ACE = angiotensin-converting enzyme ; CAD = coronary artery disease ; CO = cardiac output ; EF = ejection fraction ; F = female ; LVEDD = left ventricular
end-diastolic diameter; LVEDP = left ventricular end-diastolic pressure ; LVESD = left ventricular end-systolic diameter
; M = male ; ND not detectable ;
NYHA = New York Heart Association -, PCWP = pulmonary capillary wedge pressure
; Pt = patient ; PVR = pulmonary v.;culgr resistance ; res = resistance .
The 7.4-kb deletion (nucleotide 8637 to 16084) (Fig, 1)
was detected by amplifying total DNA with primers posi-
tioned at nucleotides 8150 to 8166 and 16159 to 16142 (574
base-pair fragment) . The conditions for polymerase chain
Table 2. Frequency of Mitochondrial DNA Deletions and
Proportion of Total Mitochondrial DNA in Control Subjects
at Autopsy
* Fetal age . kb = kilobase
; other abbreviations as in Table 1 .
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reaction amplification were the same as those described for
the 5-kb deletion, except that the annealing temperature was
52°C. The amplified products were identified by direct se-
quencing with the same oligonucleotide primers as those
used for amplification (41) .
The deleted mtDNA was quantified by amplifying specific
regions of the mtDNA in the presence of 5 juCi of sulfur-
35-dATP. As an internal control the mtDNA of each sample
was also amplified from a region where deletions have rarely
been described (31), using oligonucleotide primers from
nucleotides 800 to 825 and 1350 to 1326, which generate a
mtDNA fragment about equal in size to the amplified 5- and
7.4-kb deleted regions . Thus, quantitative data were ob-
tained despite the size dependence of the efficiency of the
polymerase chain reaction technique . Ten nanograms of
total DNA was used for one polymerase chain reaction . The
conditions for the amplification were the same as those
described for the 5-kb deletion, except that the annealing
temperature was 66°C. The ratio of deleted to total mtDNA
was ascertained by electrophoresis through a 5% nondena-
turing polyacrylamide gel with appropriate dilutions . The
gels were dried and autoradiographed at -72°C for 48 h using
Kodak XAR film with an intensifying screen, and the auto-
radiographs were quantified with a Bioimage scamicr (Milli-
pore). Several dilutions of total DNA were used for the
polymerase chain reaction to optimize the linear phase of the
exponential amplification, and 10 and 25 ng of total DNA
were used to amplify the total and deleted mtDNA, respec-
tively, these amounts having been selected after optimiza-
tion in trials with several dilutions .
Pt no . 1
2 3 4
	
5 6 7 3 9
10 11 12 13
14 15
Age (yr)/gender 25/M 45/M
45/M 46/M 461'M 481M 52/M 52/F 53/M 56/M 601M
601M 61/61
61/M 63,tM 52 - 3
Duration of symptoms (yr)
10 4 2 3 4 1
2 5 3 1
1 3 5 1 3
.1 ± 0 .6
NYHA functional class 1I
II 113 111Ill H II 11 11
11 11 II 31
I Ill
CAD
Echocardiographic finding
LVEDD (mm)
95 63 66 72 78 66 33
74 74 79 78 76 72
66 73 ± 2
LVESD (mm)
83 53 49 66 61 51 54 44 63 63 71
71 64 66 51
61 ± 3
EF
(0170
26 33 49 17 38 44
30 34
31
30 27
19 18 20 44
30 ± 3
Finding at catheterization
LVEDP (mm Hg)
8 36 27 19 26 ND ND 8 22 16
33 19 ND 29 22 22 .1 ± 2 .5
PCWP (mm Hg) 9 23
13 12 23 20 ND 4 13 23 29
21 39 ND 31 20 ± 3
PVR (Wood res units) 0 .37 0.98 3 .4 3 .53 215
IJ ND
3 .2
11
1 .7
3 .08 3 .0 3 .92 ND 5 .2
2 .6 a 0 .4
CO (liters/min) 5 .3
4
.05 4 .5 6 .7 4 .88 3.6 ND 4 .3 4.64 4 .7 2
.91 2.6 4 .58 3 .74 4 .3 4 .3 ± 0
.3
Medication
Digitalis +
Diuretic agents
-
+
ACE inhibitors
+ +
Long-acting nitrates
-
Beta-blockers +
Anticoagulant agents + +
Antiarrhythmic agents
I.
-
Case
No.
Age (yr)/
Gender
5-kb
Deletion
(To
of total
mtDNA)
7 .4-kb
Deletion
(% of total
mtDNA) Cause of Death
1 21 wk*/M ND ND 13-Trisomy
2 38 wk*/F
ND ND
Caudal anomaly
3 21M ND ND Accident
4 12/M ND ND Suicide
5 30/F 0 .124 0 .089 Suicide
6 321M 0 .112 0 .031 Suicide
7 32/F 0 .232 ND
Alcohol intoxication
8 35/F 0 .312 ND Suicide
9 38/M 0 .431 0 .286 Accident
10 411M 0 .400 0 .217 Suicide
I I 43/M 0 .306 ND
Accident
12
44/M
0 .421 0 .395
Suicide
13 441M
0.586 0 .537 Subarachnoid
hemorrhage
14 48/M 0.324
0 .353 Suicide
15 651M
0.378 0 .529 Rupture of iliac artery
16
77/M 0.650 0 .453
Accident
Mean 0.36 0 .32
tSEM ±0.05
±0.06
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MMopwMaW, The endomyocardial biopsy samples
were studied with both light and electron microscopy . Con-
secutive cryostat sections were stained with hematoxylin-
eosin, periodic acid-Schiff, Gomori trichrome, Herovici,
Sudan black and Berlin blue stains
. The specimens for
electron microscopy were fixed in 4% formaldehyde/l%
glutaraldehyde buffered to pH 7 .4 with phosphate buffer and
were postfixed in osmium tetroxide and embedded in Epon
LX-112. Ultrathin sections were contrasted with uranyl
acetate and lead citrate and examined in a Philips LS
electron microscope .
ShOWK Logistic regression analysis was used to allow
for the influence of age when testing the connection between
mitochondria) DNA deletions and idiopathic dilated c6rdio-
myopathy, using the SPSS (release 5 .0 for MS Windows,
SPSS, Inc.) program package (42) . Nonlinear curve fitting
was performed with the Marquardt algorithm using the
Statgraphics version 2 .6 (Manugistics, Inc
.) and Sigmaplot
version 4.0 (Jandel Scientific) program packages .
Results
After Southern blot hybridization of the endomyocardial
DNA failed to detect mtDNA deletions in the patients with
idiopathic dilated cardiomyopathy, the biopsy samples were
screened with the polymerase chain reaction for two of the
most common mtDNA defects : the 5-kb deletion (Cambridge
sequence map position 8469 to 13447, coding four subunits of
complex 1, one of complex IV and one of complex V of the
mitochondrial respiratory chain and five transfer RNAs) and
the 7.4-kb deletion (8637 to 16084, coding five subunits of
complex I, one of complex III, one of complex IV and one of
complex V of the mitochondrial respiratory chain and eight
transfer RNAs). The 5-kb deletion was observed in the
hearts of all of the patients with clinically typical idiopathic
dilated cardiomyopathy, the proportion of the mtDNA de-
leted varying from 0 .02% to 0.71% (0 .32 ± 0.05% [mean ±
SEM]) (Table 3) . The 7.4-kb deletion was found in only 7 of
the 15 patients and varied from 0.07% to 0 .67% (0.28 ±
0.08% [mean ± SEM]) . The 5- and 7.4-kb deletions were
detected in 12 and 9 control hearts, respectively, but it
should be noted that they were not found in the four
youngest hearts and that all of the control hearts with the
5 kb-deletions were from subjects >30 years old (Table 2) .
The 5- and 7 .4-kb deletions increased sigmoidally in extent
with advancing age in both groups (p < 0 .0001) (Fig . 2).
Logistic regression was used to test the contribution of
the mtDNA deletions to the probability of cardiomyopathy .
If the dependent variable (y) is given a value of 1 fur
cardiomyopathy and 0 for health in the model, then the odds
can be calculated from the equation (P(Y=l))I(P(Y=-'))
=
exlKbo + b lx l +	
bkXA
where the b,
. . . k
terms are the
risk coefficients for the independent variables x,
. . . k-
When deletion frequency and age and gender were in-
cluded in the model, the results of the statistics are as shown
JACC Vol. 23, No
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Table 3. Frequency of Mitochondrial DNA Deletions and
Proportion of Total Mitochondrial DNA in Patients With
Idiopathic Dilated Cardiomyopathy
mtDNA = mitochondrial DNA, other abbreviations as in Tables I and 2.
in Table 4 . Classification using the model containing the sum
of the 5- and 7.4-kb deletions was correct in 77 .4% of cases,
with a specificity of 81 .3% and a sensitivity of 73 .3%. It can
be deduced from Table 4 that there was a statistically
significant contribution of age to the occurrence of the
idiopathic cardiomyopathy . The risk coefficient of the dele-
tion frequency was negative, with a large standard error.
Because the concept of a protective effect of a deficiency in
mtDNA can be abandoned, this can be interpreted to indi-
cate that the mtDNA deletions do not contribute to the
development of idiopathic cardiomyopathy . There was no
statistically significant contribution of gender to the occur-
rence of the cardiomyopathy .
Performance of the polymerase chain reaction system for
detecting the two mtDNA deletions in the endomyocardial
biopsy samples is demonstrated in Figure 3 .
Light microscopy of the biopsy samples from the patients
with idiopathic dilated cardiomyopathy generally showed
some fibrosis but no inflammatory cells or increased iron
deposits, whereas electron microscopy revealed degenera-
tive changes, loss of myofilaments and large amounts of
lipofuscin. Three patients (Patients 6, 12 and 13, Table 3) had
accumulations of lipid droplets next to abnormally large
mitochondria (i.e., >1 pm in diameter) . Some of these
mitochondria showed structural variation, concentric cristae
and osmiophilic inclusions (Fig . 4). Ragged red fibers, as
encountered in the skeletal muscles of patients with mito-
chondrial myopathy (33,43-45), were not present, however .
Discussion
Occurrence of mtDNA deletions in heart muscle. The
results show !hat the 5- and 7 .4-kb deletions in mtDNA are
Pt
No .
Age (yr);
Gender
5-kb Deletion
(% of total mtDNA)
7 .4-kb Deletion
(% of total mtDNA)
1 251M 0 .024 ND
2 451M 0 .037 ND
3 45/M 0 .354 ND
4 461M 0 .048 ND
5 46/F 0 .341 ND
6 48/ni 0 .491 0.072
7 52/m 0.278 0.237
8 52/M 0.171 ND
9 531M 0 .520 0.230
10 56/M 0.300 TIV
11 601M 0.611 0.102
12 601M 0.708 0.457
13 61161 0.393 ND
14 61/M 0.335 0.668
15 63/M 0.128 ND
0.32 0.28
HEM ±0405 ±0.08
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Figure 2
. Plots showing the age dependence of the mitochondrial
5-kb DNA deletion (top) and the sum of the 5- and 7
.4-kilobase (kb)
deletions (bottom) in the endomyocardium of patients with idio-
pathic dilated cardiomyopathy
(solid circles) and in control hearts
(open circles) . Curves
= nonlinear fits of the logistic equation y = Ax
exp[B(x - C)]/{I + exp[B(x - Q]' to the data points ;
dotted, dashed
and solid curves
= fits to the control, idiopathic dilated cardiomy-
opathy and combined data, respectively
.
very common in patients with idiopathic dilated cardiomy-
opathy, but they seem to occur at approximately the same
frequency in an age-matched control group . Cortopassi and
Arnheim (36), studying human tissue samples collected at
autopsy, found that normal adult heart and brain tissues
contain both normal-sized and deleted mtDNA and are
therefore heteroplasmic . They estimated that the 5-kb dele-
tion accounted for -0.1% of the total mtDNA
. Corral-
Debrinski et al . (46) reported a frequency of 0 .0035% for the
5-kb mtDNA deletion in normal hearts, whereas higher
amounts of this deletion were found in ischemic hearts (from
0.02% to 0.85%) and in 10 patients with other types of heart
REMES ET AL
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Table 4 . Logistic Regression Using Idiopathic Cardiomyopathy as
the Dependent Variable
kb = kilobase,
disease (from 0 .017% to 0.16%)
. Two of these patients had
idiopathic dilated cardiom)opathy
(46) .
The proportion of the 5- and 7 .4-kb deletions determined
here in patients with idiopathic dilated cardiomyopathy and
in control hearts was higher, but it should be noted that
amplifying DNA with the polymerase chain reaction tech-
nique is highiy dependent on external circumstances, and the
discrepancies in the percents obtained in various surveys
Figure 3 . Detection of deleted mtDNA in the hearts of patients with
idiopathic dilated cardiomyopathy and in control subjects by the
polymerase chain reaction . Top, Electrophoretogram showing 0 .6-
kilobase (kb) amplified mtDNA fragments, indicating a 5-kb dele-
tion . Lane I
= control subject without the deletion ; lanes 2 and 3 =
patients with idiopathic dilated cardiomyopathy
. The fragment that
shows normal mtDNA fails to amplify under the conditions used .
Bottom, Electrophoretogram demonstrating 0 .6-kb amplified
mtDNA fragments corresponding to the 7 .4-kb deletion . Lane I =
control subject with the deletion
; lanes 2 and 3 = patients with
idiopathic dilated cardiomyopathy patients with and without the
deletion, respectively . The fragment representing normal mtDNA
fails to amplify under the conditions used .
Model
Risk
Coefficient
SE p Value
5-kb Deletion frequency
-4
.929
3 .068 0
.1051
Age
0.112 0 .045 0 .0132
Gender -0.047 0.655
0 .945
Sum of 5- and 7
.4-kb deletion frequencies -5 .326 2
.433
0 .0296
Age
0.156 0 .0597 0 .0087
Gender
0.726 1 .450 0 .617
940 REMES ET AL
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may at least partly be explained by methodologic differ-
ences .
Apt dqxudellcy. Sugiyama et al . (38) reported that the
proportion of the 7 .4-kb deletion in mtDNA from cadavers of
patients who died of noncardiac causes varies considerably
(from 0.025% to 10%), increasing exponentially with age . In
fact, it has been suggested that the increase in the frequency
of mtDNA deletions with advancing age may be one factor
contributing to presbycardia (32,34-37). The age-depen-
dence of the deletions was also seen in this series because
neither of the two fetuses who died during the intrauterine
period nor the two children in the control group had mtDN A
deletions in their hearts . However, the 7 .4-kb deletion was
not detected in all of the elderly control subjects or patients
with idiopathic dilated cardiomyopathy (Table 3) . The gen-
eral pattern, nevertheless, was for both mtDNA deletions to
increase sigruoidally with advancing age (Fig . 2) .
It has been shown that mtDNA evolves 5 to 10 times
faster than single-copy nuclear DNA and that this may be
due, at least in part, to an elevated rate of mutation in
mtDNA. The high mutation rate of mtDNA probably results
from several factors, such as lack of protective histones and
adequate repair mechanisms, continuous exposure to free
radicals produced in the mitochondrial respiratory chain and
lligh turnover amd replication rate of mtDNA also in nondi-
viding tissues (47,48) .
It has been suggested that damage to mtDNA results in
the accumulation of respiration-deficient cardiomyocytes in
advancing age and that this imposes a cardiac limit on a
person's life span (48) . It has also been suggested that
changes in mitochondrial function are involved in the char-
acteristic form of programmed cell death called apoptosis,
which occurs in embryogenesis, tissue atrophy and tumor
regression (49) . In this phenomenon the role of mtDNA
remains controversial because during apoptosis, at least
3ACC Val . 23, No. 4
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Rpre 4. Electron micrograph of endomyo-
cardial heart muscle from Patient 6 . Several
abnormal mitochondria with concentric cristae
are present . Lead citrate, uranyl acetate stain-
ing. x 12,W9 reduced by 35% .
some regions of mtDNA are relatively resistant to degrada-
tion compared with nuclear DNA (50).
Thm specificity and degree of hetereplasmy. The degree
of heteroplasmy (i .e ., deleted mtDNA relative to total
mtDNA) was found to be low in patients with idiopathic
dilated cardiomyopathy, comparable to the control hearts .
Suomalainen et al . (27) described a woman and her son who
both died of idiopathic dilated cardiomyopathy and were
shown by Southern blot. hybridization and polymerase chain
reaction analysis to have multiple large deletions in mtDNA,
so that it was estimated that in the son the mtDNA popula-
tion with deletions of different sizes comprised -50 of the
total nnDNA (27). It thus seems that these two patients
belong to a small subgroup with the hereditary form of
idiopathic dilated cardiomyopathy wits marked defects in
mtDNA, as also pointed out by these investigators .
The Kearns-Sayre syndrome belongs to a category of
mitochondrial myopathies with defects in mtDNA observed
in several tissues, including heart muscle (44) . The deletions
are heteroplasmic, and some tissues may be totally free of
mtDNA defects, emphasizing the need for elective sampling
of the target tissue in diagnostic testing (33) . Conversely, the
proportion of the mtDNA deleted in the tissues involved
ranges from 20% to 90% (44,45) and is thus much higher than
that observed here in either the patients with idiopathic
dilated cardiomyopathy or the control hearts . Despite this,
the cardiac conduction system is usually selectively affected
in the Kearns-Sayre syndrome (51-53), and only a few
patients with signs of congestive cardiomyopathy have been
described (54,55) . This raises the possibility that the Kearns-
Sayre syndrome may involve enrichment of the cells of the
conduction system, with mitochondria having mtDNA dele-
tions, or that the cardiomyocytes in general are much more
resistant to mtDNA defects than the cells of the conduction
system .
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topatholugy. The ultrastructural findings of the end
myocardial biopsy samples from the patients with idiopathic
dilated cardiomyopathy (i .e ., degeneration in myocardial
cells and increased fibrosis) resembled those described by
Schaper et al . (56) . Although ragged red fibers (accumula-
tions of abnormal mitochondria) are often found in muscle
tissue with large-scale mtDNA deletions or point mutations
in mitochondrial transfer RNA (33), none of our patients
with idiopathic dilated cardiomyopathy had any . Only some
concentric cristae, also typical of the Kearns-Sayre syF1-
drome, were found in the mitochondria of three patients with
an abundance of fat in the muscle fibers . Two of these three
patients also had large amounts of deletions (Patients 6 and
12, Table 3), but the significance of this remains unclear.
Significance of mIDNA deletions in other diseases . Many
investigations have shown that in most cases where ocular
myopathy is a key feature (Kearns-Sayre syndrome, chronic
progressive external ophthalmoplegia), a high proportion of
the total population of skeletal muscle nitDNA molecules
house large-scale deletions (31,43) . Major deletions live
also been found in cases of Pearson's marrow/pancreas
syndrome (57) . Some isolated cases of myotonic dystrophy
and dilated cardiomyopathy (23) associated with mtDNA
deletions have been described . However, our study and
another prospective analysis of 20 patients with typical
myotonic dystrophy (58) showed that mtDNA deletions d-
noyt play any significant role in the pathogenesis of these
diseases. The same is true for X-linked cardioskeletal my-
opathy with neutropenia or Barth syndrome, where mito-
chondria also show abnormal cristae but where the genetic
defect is located at Xq28 (59) .
Conclusions . We showed that the 5- and 7 .4-kb mtDNA
deletions, two of the most common, occur at the same
frequency with a low percent of heteroplasmy in the heart
muscles of patients with idiopathic dilated cardiomyopathy
and in those dying of noncardiac causes . This supports the
idea that mtDNA deletions, at least those studied here, do
not play a major role in the etiopathogenesis of idiopathic
dilated cardiomyopathy . They were not observed in the
youngest control subjects, and they increased in amount
with age, in accordance with earlier findings (33-35,37) . The
results also confirm. a recent observation of ours that endo-
myocardial tissue sampling for analysis of mtDNA by the
polymerase chain reaction technique is a feasible method for
detecting mtDNA defects in affected heart muscle (33) .
We thank Ms . Kaisu Korhonen and Ms . Anja Roukala for their expert
technical assistance .
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